Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

thomas_beck

Recipharm appoints quality management VP

March 16, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, thomas beck

Contract development and manufacturing organisation Recipharm has appointed Thomas Beck to the new senior role of vice president of quality …
Appointment
samantha_treadwell

AXON Communications adds five to London team

March 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Axon, bilotta, burns, peregrin, treadwell, ura

UK healthcare comms and PR firm AXON Communications has added five new members to its team in London. Lucie Burns …
Appointment
GSK image

GSK picks Singapore for Asian hub

March 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets

Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …
News
larry_alleva

Adaptimmune appoints PwC head to board

March 12, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lawrence Alleva, adaptimune, pwC

Clinical-stage biotech firm Adaptimmune has appointed Lawrence Alleva as a non-executive director who is also to serve as chairman of its …
Appointment
NHS image

Government pledges ‘new era’ for NHS

March 11, 2015 Research and Development, Sales and Marketing NHS, Simon Stevens, five year, reform, reorganisation, vanguard

The government is investing £200 million to back healthcare professionals to implement their own ideas for improving patient care. The …
News

New details of Innovative Medicines review disclosed

March 11, 2015 Research and Development, Sales and Marketing ABPI, NHS, NICE, PPRS, UK, george freeman, innovative medicines

The government has announced details of a sweeping review into how medicines are accessed in the UK. The Innovative Medicines …
News

NICE approves Roche’s Gazyvaro and Novartis’ Xolair

March 11, 2015 Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab

NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …
News
tom_griffiths_virgo

New head of digital for Virgo Health

March 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, tom griffiths

UK-based healthcare comms agency Virgo Health has increased its leadership team through the appointment of Tom Griffiths as head of digital.  …
Appointment

HRT pills linked to increase in clots and strokes

March 10, 2015 Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy

HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …
News
robert_castaigne_sanofi

Sanofi names audit committee chairman

March 10, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi

Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of …
Appointment
Targcept image

Targacept and Catalyst sign $100 million deal

March 9, 2015 Research and Development, Sales and Marketing CB 813d, PF-05280602, Targecept, blood disorder, catalyst biosciences

Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
News
Cancer image

Fixing what’s broken: why companies must prioritise innovation in drug development

March 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman

The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …
Feature
franklin_berger

ESSA Pharma appoints independent director

March 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing essa pharma, franklin berger

US pharma development firm ESSA Pharma has appointed Franklin Berger as an independent director. A resident of New York, Berger’s …
Appointment
Novartis image

Novartis secures first US biosimilar product

March 6, 2015 Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …
News
Keytruda image

Merck and Eisai partner on cancer therapy trial

March 6, 2015 Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025